| Personalized medicine in nasal delivery: the use of patient-specific administration parameters to improve nasal drug targeting using 3D-printed nasal replica casts ZN Warnken, HDC Smyth, DA Davis, S Weitman, JG Kuhn, RO Williams III Molecular Pharmaceutics 15 (4), 1392-1402, 2018 | 74 | 2018 |
| Selective laser sintering 3-dimensional printing as a single step process to prepare amorphous solid dispersion dosage forms for improved solubility and dissolution rate DA Davis Jr, R Thakkar, Y Su, RO Williams III, M Maniruzzaman Journal of pharmaceutical sciences 110 (4), 1432-1443, 2021 | 64 | 2021 |
| Innovations in thermal processing: hot-melt extrusion and KinetiSol® dispersing DK Tan, DA Davis Jr, DA Miller, RO Williams III, A Nokhodchi Aaps Pharmscitech 21 (8), 312, 2020 | 44 | 2020 |
| Novel formulations and drug delivery systems to administer biological solids Y Zhang, DA Davis, K AboulFotouh, J Wang, D Williams, A Bhambhani, ... Advanced drug delivery reviews 172, 183-210, 2021 | 37 | 2021 |
| A repurposed drug for brain cancer: Enhanced atovaquone amorphous solid dispersion by combining a spontaneously emulsifying component with a polymer carrier H Takabe, ZN Warnken, Y Zhang, DA Davis, HDC Smyth, JG Kuhn, ... Pharmaceutics 10 (2), 60, 2018 | 26 | 2018 |
| Selective laser sintering of a photosensitive drug: impact of processing and formulation parameters on degradation, solid state, and quality of 3D-printed dosage forms R Thakkar, DA Davis Jr, RO Williams III, M Maniruzzaman Molecular pharmaceutics 18 (10), 3894-3908, 2021 | 24 | 2021 |
| Thermally conductive excipient expands kinetiSol® processing capabilities DA Davis, DA Miller, Y Su, RO Williams AAPS PharmSciTech 21, 1-15, 2020 | 17 | 2020 |
| Formulating a heat-and shear-labile drug in an amorphous solid dispersion: Balancing drug degradation and crystallinity DA Davis Jr, DA Miller, S Santitewagun, JA Zeitler, Y Su, RO Williams III International Journal of Pharmaceutics: X 3, 100092, 2021 | 13 | 2021 |
| Complex drug delivery systems: Controlling transdermal permeation rates with multiple active pharmaceutical ingredients DA Davis, PP Martins, MS Zamloot, SA Kucera, RO Williams, HDC Smyth, ... AAPS PharmSciTech 21, 1-11, 2020 | 13 | 2020 |
| Increasing drug loading of weakly acidic telmisartan in amorphous solid dispersions through pH modification during hot-melt extrusion SA Thompson, DA Davis Jr, C Moon, RO Williams III Molecular Pharmaceutics 19 (1), 318-331, 2021 | 10 | 2021 |
| Pre-processing a polymer blend into a polymer alloy by kinetisol enables increased ivacaftor amorphous solid dispersion drug loading and dissolution SA Thompson, DA Davis Jr, DA Miller, SU Kucera, RO Williams III Biomedicines 11 (5), 1281, 2023 | 3 | 2023 |
| Home based transitional care J Leland, J Cariaga, D Davis JOURNAL OF THE AMERICAN GERIATRICS SOCIETY 60, S226-S227, 2012 | 3 | 2012 |
| Melt Extrusion SA Thompson, DA Davis Jr, JC DiNunzio, C Martin, RO Williams III, ... Formulating Poorly Water Soluble Drugs, 327-376, 2022 | 2 | 2022 |
| 3d laser sintering processes for improved drug delivery RO Williams III, M Maniruzzaman, DA Davis Jr, R Thakkar US Patent App. 18/001,411, 2023 | 1 | 2023 |
| Can the Oral Bioavailability of the Discontinued Prostate Cancer Drug Galeterone Be Improved by Processing Method? KinetiSol® Outperforms Spray Drying in a Head-to-head Comparison SA Thompson, U Gala, DA Davis Jr, S Kucera, D Miller, RO Williams III AAPS PharmSciTech 24 (6), 137, 2023 | 1 | 2023 |
| Emerging Technologies to Increase the Bioavailability of Poorly Water-Soluble Drugs DA Davis Jr, R Thakkar, M Maniruzzaman, DA Miller, RO Williams III Formulating Poorly Water Soluble Drugs, 599-650, 2022 | 1 | 2022 |
| Lipid-based formulations DA Davis Jr, HH Peng, RO Williams III Formulating Poorly Water Soluble Drugs, 253-285, 2022 | 1 | 2022 |
| Compositions for the improved delivery of drugs RO Williams III, H Takabe, DA Davis, Z Warnken US Patent App. 16/646,452, 2020 | 1 | 2020 |
| Pharmaceutical compositions and methods of manufacture using thermally conductive excipients RO Williams III, DA Davis Jr US Patent App. 17/997,260, 2023 | | 2023 |
| Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereof RO Williams III, SV Jermain, DA Davis, DA Miller US Patent App. 17/065,664, 2021 | | 2021 |
